Apple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) through its paces, signing an alliance with Johnson & Johnson.
Apple has a new competitor to its smart watch-based electrocardiogram (ECG) sensor, after Withings announced a rival at the Consumer Electronics Show in Las Vegas.
Apple made headlines earlier this month with its announcement of a new watch with an FDA-approved electrocardiogram (ECG) reader to indicate the wearer’s cardiac health.
Apple has announced that it will open up its Health Records application programming interface (API) to developers and researchers this autumn so that they can create an ecosystem of apps that use health record data to better manage medications, nutrition plans and diagnosed diseases.